183 related articles for article (PubMed ID: 17384208)
1. Evaluation of enrichment techniques for mass spectrometry: identification of tyrosine phosphoproteins in cancer cells.
Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
J Mol Diagn; 2007 Apr; 9(2):169-77. PubMed ID: 17384208
[TBL] [Abstract][Full Text] [Related]
2. Optimization of immunoaffinity enrichment and detection: toward a comprehensive characterization of the phosphotyrosine proteome of K562 cells by liquid chromatography-mass spectrometry.
Artemenko KA; Bergström Lind S; Elfineh L; Mayrhofer C; Zubarev RA; Bergquist J; Pettersson U
Analyst; 2011 May; 136(9):1971-8. PubMed ID: 21403953
[TBL] [Abstract][Full Text] [Related]
3. Immunoaffinity enrichments followed by mass spectrometric detection for studying global protein tyrosine phosphorylation.
Bergström Lind S; Molin M; Savitski MM; Emilsson L; Aström J; Hedberg L; Adams C; Nielsen ML; Engström A; Elfineh L; Andersson E; Zubarev RA; Pettersson U
J Proteome Res; 2008 Jul; 7(7):2897-910. PubMed ID: 18543961
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphoproteomics and identification of substrates of protein tyrosine phosphatase dPTP61F in Drosophila S2 cells by mass spectrometry-based substrate trapping strategy.
Chang YC; Lin SY; Liang SY; Pan KT; Chou CC; Chen CH; Liao CL; Khoo KH; Meng TC
J Proteome Res; 2008 Mar; 7(3):1055-66. PubMed ID: 18281928
[TBL] [Abstract][Full Text] [Related]
5. Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: implications for adjuvant use of kinase-inhibitory drugs.
Lim YP; Wong CY; Ooi LL; Druker BJ; Epstein RJ
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3980-7. PubMed ID: 15217928
[TBL] [Abstract][Full Text] [Related]
6. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
Rush J; Moritz A; Lee KA; Guo A; Goss VL; Spek EJ; Zhang H; Zha XM; Polakiewicz RD; Comb MJ
Nat Biotechnol; 2005 Jan; 23(1):94-101. PubMed ID: 15592455
[TBL] [Abstract][Full Text] [Related]
7. Phosphoprotein profiling of erythropoietin receptor- dependent pathways using different proteomic strategies.
Körbel S; Büchse T; Prietzsch H; Sasse T; Schümann M; Krause E; Brock J; Bittorf T
Proteomics; 2005 Jan; 5(1):91-100. PubMed ID: 15672454
[TBL] [Abstract][Full Text] [Related]
8. Detection of tyrosine phosphorylated proteins by combination of immunoaffinity enrichment, two-dimensional difference gel electrophoresis and fluorescent Western blotting.
Bergström Lind S; Hagner-McWhirter S; Elfineh L; Molin M; Jorsback A; Ohman J; Pettersson U
Biochem Biophys Res Commun; 2010 Oct; 401(4):581-5. PubMed ID: 20888324
[TBL] [Abstract][Full Text] [Related]
9. Robust enrichment of phosphorylated species in complex mixtures by sequential protein and peptide metal-affinity chromatography and analysis by tandem mass spectrometry.
Collins MO; Yu L; Husi H; Blackstock WP; Choudhary JS; Grant SG
Sci STKE; 2005 Aug; 2005(298):pl6. PubMed ID: 16118397
[TBL] [Abstract][Full Text] [Related]
10. Identification of NPM-ALK interacting proteins by tandem mass spectrometry.
Crockett DK; Lin Z; Elenitoba-Johnson KS; Lim MS
Oncogene; 2004 Apr; 23(15):2617-29. PubMed ID: 14968112
[TBL] [Abstract][Full Text] [Related]
11. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways.
Yan GR; Xiao CL; He GW; Yin XF; Chen NP; Cao Y; He QY
Proteomics; 2010 Mar; 10(5):976-86. PubMed ID: 20049867
[TBL] [Abstract][Full Text] [Related]
12. Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation.
Yang F; Stenoien DL; Strittmatter EF; Wang J; Ding L; Lipton MS; Monroe ME; Nicora CD; Gristenko MA; Tang K; Fang R; Adkins JN; Camp DG; Chen DJ; Smith RD
J Proteome Res; 2006 May; 5(5):1252-60. PubMed ID: 16674116
[TBL] [Abstract][Full Text] [Related]
13. Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line.
Giorgianni F; Zhao Y; Desiderio DM; Beranova-Giorgianni S
Electrophoresis; 2007 Jun; 28(12):2027-34. PubMed ID: 17487921
[TBL] [Abstract][Full Text] [Related]
14. Identification of tyrosine-phosphorylated proteins associated with lung cancer metastasis using label-free quantitative analyses.
Wu HY; Tseng VS; Chen LC; Chang HY; Chuang IC; Tsay YG; Liao PC
J Proteome Res; 2010 Aug; 9(8):4102-12. PubMed ID: 20572634
[TBL] [Abstract][Full Text] [Related]
15. Identification of p65-associated phosphoproteins by mass spectrometry after on-plate phosphopeptide enrichment using polymer-oxotitanium films.
Wang WH; Palumbo AM; Tan YJ; Reid GE; Tepe JJ; Bruening ML
J Proteome Res; 2010 Jun; 9(6):3005-15. PubMed ID: 20380454
[TBL] [Abstract][Full Text] [Related]
16. Phosphoproteome analysis.
Raggiaschi R; Gotta S; Terstappen GC
Biosci Rep; 2005; 25(1-2):33-44. PubMed ID: 16222418
[TBL] [Abstract][Full Text] [Related]
17. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
Ethier SP; Kokeny KE; Ridings JW; Dilts CA
Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics.
van der Mijn JC; Labots M; Piersma SR; Pham TV; Knol JC; Broxterman HJ; Verheul HM; Jiménez CR
J Proteomics; 2015 Sep; 127(Pt B):259-63. PubMed ID: 25890253
[TBL] [Abstract][Full Text] [Related]
19. Relative quantification of erythropoietin receptor-dependent phosphoproteins using in-gel 18O-labeling and tandem mass spectrometry.
Körbel S; Schümann M; Bittorf T; Krause E
Rapid Commun Mass Spectrom; 2005; 19(16):2259-71. PubMed ID: 16021614
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases.
Torres M; Hall FL; O'Neill K
J Immunol; 1993 Feb; 150(4):1563-77. PubMed ID: 7679431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
